Jad Chahoud

2.7k citations
115 papers · 1.8k · 1 hit paper · h-index 25

Impact in

Papers in

Jad Chahoud

105 papers receiving 1.8k citations

Jad Chahoud's Hit Papers

Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial 2023 · 143 citations
1430+1+2Years since publication4080120

Peers

Jad Chahoud
Comparison fields: 5 of 82
  • Surgery 851
  • Pulmonary and Respiratory Medicine 422
  • Oncology 343
  • Epidemiology 352
  • Rheumatology 156
Replace Hemant B Tongaonkar with:
Hemant B Tongaonkar India
Joel A. Werier Canada
Gerson Paull United States
Masashi Yamashiro Japan
Gil Dubernard France
Edgardo L. Yordan United States
Yoichi Aoki Japan
Yukitaka Yamashita Japan
Catherine Meg McLachlin Canada
Wim Demey Belgium
Jad Chahoud relative to Hemant B Tongaonkar India Hemant B Tongaonkar's profile →
Citations per field
00.5×2×4×6×8.3×
Hemant B Tongaonkar · 1×
Citations per year

Countries citing papers authored by Jad Chahoud

Since Specialization
Citations

This map shows the geographic impact of Jad Chahoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jad Chahoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jad Chahoud more than expected).

Fields of papers citing papers by Jad Chahoud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jad Chahoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jad Chahoud. The network helps show where Jad Chahoud may publish in the future.

Co-authors

The 25 scholars most cited alongside Jad Chahoud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jad Chahoud Line = papers co-authored together Jad Chahoud links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial
Hit paper breakdown →
2023143
2 2014136
3 2015111
4 201979
5 202058
6 202156
7 202251
8 202149
9 202049
10 202048
11 201541
12 202040
13 202136
14 202236
15 202034
16 202233
17 202131
18 202030
19 202030
20 202030

About Jad Chahoud

Jad Chahoud is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Cancer Research, having authored 115 papers that have together received 1.8k indexed citations. Recurring topics across this work include Genital Health and Disease (45 papers), Renal cell carcinoma treatment (27 papers), Cervical Cancer and HPV Research (20 papers), Colorectal and Anal Carcinomas (15 papers), Cancer Immunotherapy and Biomarkers (11 papers), Bladder and Urothelial Cancer Treatments (10 papers), Urologic and reproductive health conditions (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Surgery (851 citations), Pulmonary and Respiratory Medicine (422 citations), Oncology (343 citations), Epidemiology (352 citations) and Rheumatology (156 citations). Jad Chahoud has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Philippe E. Spiess, Souha Sami Kanj, Zeina Adnan Kanafani, Curtis Alvin Pettaway, Andrea Necchi, Ali J. Hajiran, Alyssa G. Rieber, Vidhu B. Joshi, Stephen Keith Tyring and Peter L. Rady. Their work appears in journals such as Cancers, Urologic Oncology Seminars and Original Investigations, The Journal of Urology, Annals of Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact